Marathon Trading Investment Management’s Celgene Corp CELG Stock Holding History

Marathon Trading Investment Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,000	Closed	-$397K	–	230
2019 Q3	$397K	Buy	+4,000	New	+$380K	0.07%	144
2019 Q2	–	Sell	-10,807	Closed	-$1.02M	–	317
2019 Q1	$1.02M	Sell	10,807 -8,649	-44%	-$756K	0.12%	132
2018 Q4	$1.25M	Buy	+19,456	New	+$1.44M	0.07%	122
2015 Q1	–	Sell	-4,500	Closed	-$503K	–	708
2014 Q4	$503K	Buy	+4,500	New	+$475K	0.01%	418

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Marathon Trading Investment Management's CELG Position: Q4 2019 in Review

Marathon Trading Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,000 shares — an estimated $397K sold.

Marathon Trading Investment Management first reported a position in CELG in Q4 2014 and held it in 4 quarters. The position peaked at $1.25M in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Marathon Trading Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Marathon Trading Investment Management sold 4,000 Celgene Corp shares in Q4 2019, an estimated $397K.
Marathon Trading Investment Management first reported a position in Celgene Corp in Q4 2014 and held it in 4 quarters.
Marathon Trading Investment Management's Celgene Corp position peaked at $1.25M in Q4 2018.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Marathon Trading Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.